Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Comparison of the Human Acellular Vessel (HAV) With ePTFE Grafts as Conduits for Hemodialysis

NCT: NCT02644941 · COMPLETED

NCT IDNCT02644941
StatusCOMPLETED
Start Date2016-05-24
Completion2023-09
SponsorHumacyte, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

The main purpose of this study is to compare the Human Acellular Vessel (HAV) with ePTFE grafts when used for hemodialysis access.

Frequently Asked Questions

What is Comparison of the Human Acellular Vessel (HAV) With ePTFE Grafts as Conduits for Hemodialysis?

Comparison of the Human Acellular Vessel (HAV) With ePTFE Grafts as Conduits for Hemodialysis is a clinical trial registered under NCT02644941. Current status: COMPLETED.

What is the status of NCT02644941?

The current status of NCT02644941 (Comparison of the Human Acellular Vessel (HAV) With ePTFE Grafts as Conduits for Hemodialysis) is: COMPLETED.

When did Comparison of the Human Acellular Vessel (HAV) With ePTFE Grafts as Conduits for Hemodialysis start?

Comparison of the Human Acellular Vessel (HAV) With ePTFE Grafts as Conduits for Hemodialysis started on 2016-05-24.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑